Cargando…
New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
BACKGROUND: Associations between type 2 diabetes, anti-diabetic medications and pancreatic cancer are controversial. This study aims to clarify such associations with new-onset type 2 diabetes and repeated measurements of glycated haemoglobin (HbA1c) levels. METHODS: A nested case–control study was...
Autores principales: | Lu, Yunxia, Rodríguez, Luis Alberto García, Malgerud, Linnéa, González-Pérez, Antonio, Martín-Pérez, Mar, Lagergren, Jesper, Bexelius, Tomas S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705881/ https://www.ncbi.nlm.nih.gov/pubmed/26575601 http://dx.doi.org/10.1038/bjc.2015.353 |
Ejemplares similares
-
Reply to ‘Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer''
por: Lu, Yunxia, et al.
Publicado: (2016) -
Does cancer risk increase with HbA(1c), independent of diabetes?
por: de Beer, J C, et al.
Publicado: (2014) -
Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'
por: Badrick, Ellena, et al.
Publicado: (2016) -
Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
por: Edqvist, Jon, et al.
Publicado: (2021) -
Type 2 diabetes medication and HbA1c levels in North Karelia Finland, 2013–2019
por: Wikström, Katja, et al.
Publicado: (2022)